BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36980751)

  • 1. Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival.
    Porter RJ; Murray GI; Hapca S; Hay A; Craig SG; Humphries MP; James JA; Salto-Tellez M; Brice DP; Berry SH; McLean MH
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis.
    Wang CQ; Huang BF; Wang Y; Tang CH; Jin HC; Shao F; Shao JK; Wang Q; Zeng Y
    Sci Rep; 2020 Oct; 10(1):18587. PubMed ID: 33122771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma.
    Yao X; Zhao G; Yang H; Hong X; Bie L; Liu G
    J Cancer Res Clin Oncol; 2010 May; 136(5):677-84. PubMed ID: 19898867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8
    Porter RJ; Murray GI; Alnabulsi A; Humphries MP; James JA; Salto-Tellez M; Craig SG; Wang JM; Yoshimura T; McLean MH
    J Pathol Clin Res; 2021 Sep; 7(5):495-506. PubMed ID: 33988317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype.
    Porter RJ; Murray GI; Brice DP; Petty RD; McLean MH
    Br J Cancer; 2020 Feb; 122(4):545-554. PubMed ID: 31831860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection.
    Yang F; Zeng Z; Li J; Zheng Y; Wei F; Ren X
    Front Oncol; 2018; 8():604. PubMed ID: 30619746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
    Ueda M; Takahashi Y; Shinden Y; Sakimura S; Hirata H; Uchi R; Takano Y; Kurashige J; Iguchi T; Eguchi H; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2014 Oct; 34(10):5357-62. PubMed ID: 25275029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
    Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
    Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
    Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
    Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
    Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
    Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.
    Peng RQ; Wu XJ; Ding Y; Li CY; Yu XJ; Zhang X; Pan ZZ; Wan DS; Zheng LM; Zeng YX; Zhang XS
    BMC Cancer; 2010 Sep; 10():496. PubMed ID: 20846416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer.
    Möller K; Blessin NC; Höflmayer D; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Zalewski K; Hinsch A; Neipp M; Mofid H; Lárusson H; Daniels T; Isbert C; Coerper S; Ditterich D; Rupprecht H; Goetz A; Bernreuther C; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Perez D; Izbicki JR; Clauditz TS; Marx AH
    Acta Oncol; 2021 Sep; 60(9):1210-1217. PubMed ID: 34092167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 overexpression correlates with poor prognosis in early-stage squamous cervical cancer.
    Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Chai F; Wang X; Guo J; Tian L
    Tumour Biol; 2015 Nov; 36(11):9039-47. PubMed ID: 26084608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.
    Zhou G; Noordam L; Sprengers D; Doukas M; Boor PPC; van Beek AA; Erkens R; Mancham S; Grünhagen D; Menon AG; Lange JF; Burger PJWA; Brandt A; Galjart B; Verhoef C; Kwekkeboom J; Bruno MJ
    Oncoimmunology; 2018; 7(7):e1448332. PubMed ID: 29900067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Expression of high mobility group box-1 in colorectal cancer and its clinical significance].
    Li Z; Wang H; Song B; Sun Y; Han J; Xu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):616-9. PubMed ID: 26108781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.
    Park JH; Powell AG; Roxburgh CS; Horgan PG; McMillan DC; Edwards J
    Br J Cancer; 2016 Mar; 114(5):562-70. PubMed ID: 26859693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-216b functions as a tumor suppressor by targeting HMGB1-mediated JAK2/STAT3 signaling way in colorectal cancer.
    Chen X; Liu X; He B; Pan Y; Sun H; Xu T; Hu X; Wang S
    Am J Cancer Res; 2017; 7(10):2051-2069. PubMed ID: 29119054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.